Robotic vs Software-Only TKA Planning
Robotic total knee arthroplasty improves some accuracy metrics but its cost is the adoption barrier. A look at where a software-only, vendor-neutral pre-op planning layer delivers the planning value without the capital cost.
Key takeaways
Robotic total knee arthroplasty (TKA) is now used in a large share of cases, and it does improve certain intra-operative accuracy metrics. But the debate among senior arthroplasty surgeons has shifted from does the robot cut accurately to is the robot worth its cost. The capital price of a robot, plus per-case consumables, is hard to justify when experienced hands already achieve excellent stability, and randomized evidence for better patient-reported outcomes remains limited. What almost no one disputes is the value of the pre-operative planning layer: the ability to do the "surgery before the surgery" virtually, anticipate problems, and standardize the plan. That planning value is separable from the robot. A software-only, vendor-neutral, computed-tomography-based planner can deliver it without the capital cost, which is exactly where a tool like Salnus is positioned, currently Research Use Only (RUO), not a cleared device.
The debate is about the robot, not the plan
Ask a room of arthroplasty surgeons whether a robot is mandatory for a knee replacement and many will say no. In experienced hands, primary TKA already succeeds at a high rate. Robotic systems help move certain metrics, for example reducing outliers in component position, but the incremental gain on hard outcomes is modest and the cost is large: a capital system plus recurring per-case consumables.
The most rigorous syntheses are cautious. A 2021 systematic review by Kazarian, Barrack and colleagues concluded that component malalignment is not a significant driver of the well-documented 15 to 20 percent dissatisfaction rate after TKA, although rotation does relate to implant survival. In other words, precision alone has not translated into a clear satisfaction advantage. This is the crux of the cost-effectiveness argument against robotics.
What surgeons actually defend: planning and data
When the same surgeons discuss where the value really sits, they point not at the robot arm but at two things: the pre-operative plan and the data. The plan lets a surgeon rehearse the case, foresee gap and tracking problems, and enter the operating room with a defined target. The data captured across cases is a tool for continuous learning and refinement.
Both of these are software functions. Neither requires a capital robot. That is the strategic opening: decouple the planning layer that surgeons value from the expensive, cost-contested hardware.
Where a software-only planner fits
A software-only, computed-tomography-based planner can compute the same pre-operative decisions a robotic plan does, without the robot:
| Dimension | Robotic system | Software-only planner |
|---|---|---|
| Pre-op 3D model + measurements | Yes (CT or imageless) | Yes (CT-based) |
| Alignment strategy comparison | Usually one workflow | Multiple philosophies side by side |
| Capital cost | High | None |
| Per-case consumables | Yes | No physical consumables |
| Implant lock-in | Tied to the vendor's implant | Implant-agnostic |
| Intra-op execution | Robot-assisted cuts | Feeds any robot, guide, or manual |
The point is not to replace the robot. It is to be the vendor-neutral pre-operative brain that feeds any robot, patient-specific guide, or manual workflow, and to serve the majority of TKAs still done without a robot. For a fuller market view, see our comparison of orthopedic 3D planning software and our note on how planning tools complement robotic systems.
The honest caveat
This is a decision-support and reproducibility argument, not a claim that planning by itself improves outcomes. The evidence that better planning changes hard endpoints is still developing, and benefit appears strongest at the margins, for example less-experienced surgeons or complex phenotypes, rather than universally. The right framing is: standardized, reproducible, patient-specific planning that a surgeon owns, at a fraction of the cost of a robot, and without locking the choice of implant.
Bottom line
The robotics cost debate is not a headwind for pre-operative planning software. It is a tailwind. The layer surgeons defend is the plan and the data, and that layer does not need a million-dollar robot. A vendor-neutral, implant-agnostic, CT-based planner delivers it directly. Salnus builds toward exactly this, as Research Use Only software today, with the surgeon in control of the plan.
Reviewed by the Salnus biomedical engineering team.